|
|
|
The University of Nebraska's governing board on Friday voted not to place tighter restrictions on embryonic stem cell research than those outlined under federal guidelines, which were expanded after President Barack Obama took...
Kidney stones, malaria, Lyme disease, depression and respiratory illness all may increase with global warming, researchers at Harvard Medical School say. By Jim Efstathiou Jr Kidney stones, malaria, Lyme disease, depression and...
Findings from the Phase III EINSTEIN-Extension study will be presented in the Late Breaking Abstract Session on December 8, 2009, (7:30 am EST, Hall F, Ernest N. Morial Convention Center) at the 51st Annual Meeting of the...
to be Introduced in 2010 GREENSBORO, N.C., Nov 19, 2009 -- You should be aware that the forward-looking statements included herein represent management's current judgment and expectations, but our actual results, events and...
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced positive results from a recently completed phase II clinical study of its ToleroMune(R) cat allergy therapy, which successfully identified the...
An emerging body of evidence suggests that the changing global climate is already affecting infectious disease transmission patterns. As noted today in a symposium at the 58th annual meeting of the American Society of Tropical...
Inflammatory bowel disease (IBD) is a chronic autoimmune disorder – encompassing both Crohn’s disease and ulcerative colitis – that affects more than a million people in the United States. Normally, our immune system works to...
Sucampo Pharma Europe Ltd., a subsidiary of Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP), announced that Swissmedic, the Swiss Agency for Therapeutic Products, has granted a marketing authorization for Amitiza® (lubiprostone)...
Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors (PNTs), despite such tumors being commonly considered resistant to radiation therapy, according to a...
POLITICO recently published an editorial by Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Ken Johnson. In the editorial, Johnson makes the case for health reform and reaffirm's PhRMA's...
